Morphological and functional demonstration of rat dura mater mast cell-neuron interactions in vitro and in vivo

Brain Research

Volumn 849, Issue 1-2, 1999, Pages 1-15

  Rozniecki, Jacek J ^a   Dimitriadou, Violetta ^a   Lambracht Hall, Mona ^a   Pang, Xinzhu ^a   Theoharides, Theoharis C ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dura; Estradiol; Histamine; Mast cell; Migraine; Neuron; Neuropeptide; Secretion; Stress; Substance P

Indexed keywords

CARBACHOL; CORTICOTROPIN RELEASING FACTOR; ESTRADIOL; ESTROGEN RECEPTOR; HEPARIN; HISTAMINE; NEUROPEPTIDE; PROTEINASE; SUBSTANCE P;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; CONTROLLED STUDY; DURA MATER; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MAST CELL; MORPHOLOGY; NERVE CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SCANNING ELECTRON MICROSCOPY; STRESS;

EID: 0032734056     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01855-7     Document Type: Article

References (92)

1. Ali H., Leung K.B.P., Pearce F.L., Hayes N.A., Foreman J.C. Comparison of the histamine-releasing action of substance P on mast cells and basophils from different species and tissues. Int. Arch. Allergy Appl. Immunol. 79:1986;413-418.
2. Anthony M., Lance J.W. Histamine and serotonin in cluster headache. Arch. Neurol. 25:1971;225-231.
3. Bienenstock J., Tomioka M., Matsuda H., Stead R.H., Quinonez G., Simon G.T., Coughlin M.D., Denburg J.A. The role of mast cells in inflammatory processes: evidence for nerve mast cell interactions. Int. Arch. Allergy Appl. Immunol. 82:1987;238-243.
4. Bradding P., Okayama Y., Howarth P.H., Church M.K., Holgate S.T. Heterogeneity of human mast cells based on cytokine content. J. Immunol. 155:1995;297-307.
5. Brandes L.J., Macdonald L.M., Bogdanovic R.P. Evidence that the antiestrogen binding site is a histamine or histamine-like receptor. Biochem. Biophys. Res. Commun. 126:1985;905-910.
6. Buzzi M.G., Dimitriadou V., Theoharides T.C., Moskowitz M.A. 5-Hydroxytryptamine receptor agonists for the abortive treatment of vascular headaches block mast cell, endothelial and platelet activation within the rat dura mater after trigeminal stimulation. Brain Res. 583:1992;137-149.
7. Buzzi M.G., Moskowitz M.A. The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br. J. Pharmacol. 99:1990;202-206.
8. Castagliuolo I., LaMont J.T., Qiu B., Fleming S.M., Bhaskar K.R., Nikulasson S.T., Kornetsky C., Pothoulakis C. Acute stress causes mucin release from rat colon: role of corticotropin releasing factor and mast cells. Am. J. Physiol. 271:1996;884-892.
9. 1 receptor mRNA expression. J. Neurosci. 10:1995;6340-6350.
10. Chalmers D.T., Lovenberg T.W., Grigoriadis D.E., Behan D.P., DeSouza E.B. Corticotropin-releasing factor receptors: from molecular biology to drug design. TIPS. 17:1996;166-172.
11. Chrousos G.P. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N. Engl. J. Med. 332:1995;1351-1362.
12. v mice. FASEB J. 12:1998;1693-1700.
13. De Felipe C., Herrero J.F., O'Brien J.A., Palmer J.A., Doyle C.A., Smith A.J.H., Laird J.M.A., Belmonte C., Cervero F., Hunt S.P. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature. 392:1998;394-397.
14. Dimitriadou V., Aubineau P., Taxi J., Seylaz J. Ultrastructural evidence for a functional unit between nerve fibers and type II cerebral mast cells in the cerebral vascular wall. Neuroscience. 22:1987;621-630.
15. Dimitriadou V., Buzzi M.G., Moskowitz M.A., Theoharides T.C. Trigeminal sensory fiber stimulation induces morphologic changes reflecting secretion in rat dura mast cells. Neuroscience. 44:1991;97-112.
16. Dimitriadou V., Buzzi M.G., Theoharides T.C., Moskowitz M.A. Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat dura mater and tongue following antidromic trigeminal stimulation. Neuroscience. 48:1992;187-203.
17. Dimitriadou V., Henry P., Brochet B., Mathiau P., Aubineau P. Cluster headache: ultrastructural evidence for mast cell degranulation and interaction with nerve fibers in the human temporal artery. Cephalalgia. 10:1990;221-228.
18. V. Dimitriadou, M. Lambracht-Hall, T.C. Theoharides, Can inhibition of carbachol or substance induced selective release from mast cells associated with analgesia, Pain, 5 (suppl) (1990) 514-abs.
19. Dimitriadou V., Rouleau A., Trung Tuong M.D., Newlands G.J.F., Miller H.R.P., Luffau G., Schwartz J.-C., Garbarg M. Functional relationships between sensory nerve fibers and mast cells of dura mater in normal and inflammatory conditions. Neuroscience. 77:1997;829-839.
20. Dimitriadou V., Rouleau A., Tuong T., Ligneau X., Newlands G.F.J., Miller H.R.P., Schwartz J.-C., Garbarg M. Rat cerebral mast cells undergo phenotype changes during development. Dev. Brain. Res. 97:1996;29-41.
21. Dropp J.J. Mast cells in the mammalian brain: I. Distribution. Acta Anat. 94:1976;1-21.
22. Dropp J.J. Mast cells in the human brain. Acta Anat. 105:1979;505-513.
23. Edvinsson L. Experimental headache models in animals and humans. TIPS. 16:1995;5-9.
24. Edvinsson L., Cervos-Navarro J., Larsson L.I., Owman C., Ronnberg A.L. Regional distribution of mast cells containing histamine, dopamine or 5-hydroxytryptamine in the mammalian brain. Neurology. 27:1977;878-884.
25. Edvinsson L., Owman C., Sjöberg N.O. Autonomic nerves, mast cells and amine receptors in human brain vessels. A histochemical and pharmacological study. Brain Res. 115:1976;377-393.
26. Fewtrell C.M.S., Foreman J.C., Jordan C.C., Oehme P., Renner H., Stewart J.M. The effects of substance P on histamine and 5-hydroxytryptamine release in the rat. J. Physiol. 330:1982;393-411.
27. Foreman J.C. Neuropeptides and the pathogenesis of allergy. Allergy. 42:1987;1-11.
28. Foreman J.C. Peptides and neurogenic inflammation. Brain Res. Bull. 43:1987;386-398.
29. Galli S.J. New concepts about the mast cell. N. Engl. J. Med. 328:1993;257-265.
30. Glover V., Sandler M. Can the vascular and neurogenic theories of migraine be reconciled? TIPS. 10:1989;1-3.
31. Goadsby P.J., Edvinsson L., Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann. Neurol. 28:1990;183-187.
32. Hakanson R., Leander S., Andersson R.G., Horig J. Substance P antagonists release histamine from peritoneal mast cells. Acta Physiol. Scand. 117:1983;319-320.
33. Heatley R.V., Denburg J.A., Bayer N., Bienenstock J. Increased plasma histamine levels in migraine patients. Clin. Allergy. 12:1982;145-149.
34. Ibrahim M.Z. The mast cells of the mammalian central nervous system: Part I. Morphology, distribution and histochemistry. J. Neurol. Sci. 21:1974;431-478.
35. Janiszewski J., Bienenstock J., Blennerhassett M.G. Picomolar doses of substance P trigger electrical responses in mast cells without degranulation. Am. J. Physiol. 267:1994;C138-C145.
36. Karalis K., Louis J.M., Bae D., Hilderbrand H., Majzoub J.A. CRH and the immune system. J. Neuroimmunol. 72:1997;131-136.
37. Karalis K., Sano H., Redwine J., Listwak S., Wilder R.L., Chrousos G.P. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science. 254:1991;421-423.
38. Keller J.T., Dimlich R.V., Zuccarello M., Lanker L., Strauss T.A., Fritts M.J. Influence of the sympathetic nervous system as well as trigeminal sensory fibers on rat dural mast cells. Cephalalgia. 11(5):1991;215-221.
39. Keller J.T., Marfurt C.F. Peptidergic and serotoninergic innervation of the rat dura mater. J. Comp. Neurol. 309:1991;515-534.
40. Kines K.C., Powell H.C. Mast cell interactions with the nervous system: relationship to mechanisms of disease. J. Neuropathol. Exp. Neurol. 56:1997;627-640.
41. Klein L.M., Lavker R.M., Matis W.L., Murphy G.F. Degranulation of human mast cells induces an endothelial antigen central to leukocyte adhesion. Proc. Natl. Acad. Sci. U.S.A. 86:1989;8972-8976.
42. Krabbe A.A., Olesen J. Headache provocation by continuous intravenous infusion of histamine, clinical results and receptor mechanisms. Pain. 8:1980;253-259.
43. Kubler A., Rothacher G., Knappertz V.A., Kramer G., Nink M., Beyer J., Lehnert H. Intra and extracerebral blood flow changes and flushing after intravenous injection of human corticotropin-releasing hormone. Clin. Invest. 72:1994;331-336.
44. Kudrow L., Kudrow D.B., Sandweiss J.H. Rapid and sustained relief of migraine attacks with intranasal lidocaine: preliminary findings. Headache. 35:1995;79-82.
45. Lambracht-Hall M., Dimitriadou V., Theoharides T.C. Migration of mast cells in the developing rat brain. Dev. Brain Res. 56:1990;151-159.
46. Lambracht-Hall M., Konstantinidou A.D., Theoharides T.C. Serotonin release from rat brain mast cells in vitro. Neuroscience. 39:1990;199-207.
47. LaMerte F.P., Merchant J.A., Casale T.B. Acute systemic reactions to carbonless copy paper associate with histamine release. JAMA. 260:1988;242-243.
48. Liberski P.P., Mirecka B. Mast cells in cluster headache: ultrastructure, release pattern and possible pathogenetic significance. Cephalalgia. 4:1984;101-106.
49. Liberski P.P., Prusinski A. Further observations on the mast cells over the painful region in cluster headache patients. Headache. 22:1982;115-117.
50. Lowman M.A., Rees P.H., Benyon R.C., Church M.K. Human mast cell heterogeneity: histamine release from mast cells dispersed from skin, lung, adenoids, tonsils, and colon in response to IgE-dependent and nonimmunologic stimuli. J. Allergy Clin. Immunol. 81:1988;590-597.
51. Lutz E., Chan W., Track N.S., Goth A., Said S.I. Release of vasoactive intestinal polypeptide in mast cells by histamine liberators. Nature. 275:1978;661-662.
52. Mannaioni P.F., Masini E., Pistelli A., Salvemini D., Vane J.R. Mast cells as a source of superoxide anions and nitric oxide-like factor: relevance to histamine release. Int. J. Tissue React. 13:1991;271-278.
53. Marshall J.S., Waserman S. Mast cells and the nerves - potential interactions in the context of chronic disease. Clin. Exp. Allergy. 25:1995;102-110.
54. Matsuda H., Kawakita K., Kiso Y., Nakano T., Kitamura Y. Substance P induces granulocyte infiltration through degranulation of mast cells. J. Immunol. 142:1989;927-931.
55. Merchenthaler I., Hynes M.A., Vingh S., Schally A.V., Petrusz P. Immunocytochemical localization of corticotropin-releasing factor (CRF) in the rat spinal cord. Brain Res. 275:1983;373-377.
56. Moskowitz M.A. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. TIPS. 13:1992;307-311.
57. Naukkarinen A., Harvima I., Paukkonen K., Aalto M.-L., Horsmanheimo M. Immunohistochemical analysis of sensory nerves and neuropeptides and their contacts with mast cells in developing and mature psoriatic lesions. Arch. Dermatol. Res. 285:1993;341-346.
58. Newson B., Dahlström A., Enerbäck L., Ahlman H. Suggestive evidence for a direct innervation of mucosal mast cells. Neuroscience. 10:1983;565-570.
59. Olesen J., Friberg L., Olesen T.S., Iversen H.K., Lassen N.A., Andersen A.R., Karle A. Timing and topography of cerebral blood flow, aura and headache during migraine attacks. Ann. Neurol. 28:1990;791-798.
60. Olesen J., Thomsen L.L., Iversen H. Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol. Sci. 15:1994;149-153.
61. Olness K., Hall H., Rozniecki J.J., Schmidt W., Boucher W., Theoharides T.C. Mast cell activation in children with migraine before and after training in self-regulation. Headache. 39:1999;101-107.
62. Olsson Y. Mast cells in the nervous system. Int. Rev. Cytol. 24:1968;27-70.
63. Orr E.L., Pace K.R. The significance of dura mast cells as a source of histamine in the mouse brain. J. Neurochem. 42:1984;727-732.
64. Ottosson A., Edvinsson L. Release of histamine from dural mast cells by substance P and calcitonin gene-related peptide. Cephalalgia. 17:1997;166-174.
65. Pang X., Cotreau-Bibbo M.M., Sant G.R., Theoharides T.C. Bladder mast cell expression of high affinity estrogen receptors in patients with interstitial cystitis. Br. J. Urol. 75:1995;154-161.
66. Pang X., Letourneau R., Rozniecki J.J., Wang L., Theoharides T.C. Definitive characterization of rat hypothalamic mast cells. Neuroscience. 73:1996;889-902.
67. Pollard H., Bischoff S., Llorens-Cortes C., Schwartz J.C. Histidine decarboxylase and histamine in discrete nuclei of rat hypothalamus and the evidence for mast cells in the median eminence. Brain Res. 118:1976;509-513.
68. Purcell W.M., Westgate C., Atterwill C.K. Rat brain mast cells: an in vitro paradigm for assessing the toxic effects of neurotropic therapeutics. Neurotoxicology. 17:1996;845-850.
69. Rivest S., Laflamme N., Nappi R.E. Immune challenge and immobilization stress induce transcription of the gene encoding the CRF receptor in selective nuclei of the rat hypothalamus. J. Neurosci. 15:1995;2680-2695.
70. Rodewald H.-R., Dessing M., Dvorak A.M., Galli S.J. Identification of a committed precursor for the mast cell lineage. Science. 271:1996;818-822.
71. Shanahan F., Denburg J.A., Fox J., Bienenstock J., Befus D. Mast cell heterogeneity: effects of neuroenteric peptides on histamine release. J. Immunol. 135:1985;1331-1337.
72. Silver R., Silverman A.-J., Vitkovic L., Lederhendler I.I. Mast cells in the brain: evidence and functional significance. Trends Neurosci. 19:1996;25-31.
73. Skofitsch G., Savitt J.M., Jacobowitz D.M. Suggestive evidence for a functional unit between mast cells and substance P fibers in the rat diaphragm and mesentery. Histochemistry. 82:1985;5-8.
74. Skofitsch G., Zamir N., Helke C.J., Savitt J.M., Jacobowitz D.M. Corticotropin-releasing factor-like immunoreactivity in sensory ganglia and capsaicin sensitive neurons of the rat central nervous system: colocalization with other neuropeptides. Peptides. 6:1985;307-318.
75. Sternberg E.M., Chrousos G.P., Wilder R.L., Gold P.W. The stress response and the regulation of inflammatory disease. Ann. Intern. Med. 117:1992;854-866.
76. Stead R.H., Tomioka M., Quinonez G., Simon G.T., Felten S.Y., Bienenstock J. Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves. Proc. Natl. Acad. Sci. USA. 84:1987;2975-2979.
77. Strassman A.M., Raymond S.A., Burstein R. Sensitization of meningeal sensory neurons and the origin of headaches. Nature. 384:1996;560-564.
78. Suda T., Tomori N., Tozawa F., Mouri T., Demura H., Shizume K. Distribution and characterization of immunoreactive corticotropin-releasing factor in human tissues. J. Clin. Endocrinol. Metab. 59:1984;861-866.
79. Suzuki H., Miura S., Liu Y.Y., Tsuchiya M., Ishii H. Substance P induces degranulation of mast cells and leukocyte adhesion to venular endothelium. Peptides. 16:1995;1447-1452.
80. Theoharides T.C. Mast cells and migraines. Perspect. Biol. Med. 26:1983;672-675.
81. Theoharides T.C. Mast cells: the immune gate to the brain. Life Sci. 46:1990;607-617.
82. Theoharides T.C. Mast cell: a neuroimmunoendocrine master player. Int. J. Tissue React. 18:1996;1-21.
83. Theoharides T.C., Dimitriadou V., Letourneau R.J., Rozniecki J.J., Vliagoftis H., Boucher W.S. Synergistic action of estradiol and myelin basic protein on mast cell secretion and brain demyelination: changes resembling early stages of demyelination. Neuroscience. 57:1993;861-871.
84. Theoharides T.C., Singh L., Boucher W., Pang X., Letourneau R., Webster E., Chrousos G. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its pro-inflammatory effects. Endocrinology. 139:1998;403-413.
85. Theoharides T.C., Spanos C.P., Pang X., Alferes L., Ligris K., Letourneau R., Rozniecki J.J., Webster E., Chrousos G. Stress-induced intracranial mast cell degranulation. A corticotropin releasing hormone-mediated effect. Endocrinology. 136:1995;5745-5750.
86. Trnovsky J., Letourneau R.J., Haggag E., Boucher W., Theoharides T.C. Quercetin-induced expression of rat mast cell protease II and accumulation of secretory granules in rat basophilic leukemia cells. Biochem. Pharmacol. 46:1993;2315-2326.
87. Udelsman R., Gallucci W.T., Bacher J., Loriaux D.L., Chrousos G.P. Hemodynamic effects of corticotropin-releasing hormone in the anesthetized cynomolgus monkey. Peptides. 7:1986;465-467.
88. Udelsman R., Harwood J.P., Millan M.A., Chrousos G.P., Zimlichman R., Catt K.J., Aguilera G. Functional corticotropin-releasing factor receptors in the primate peripheral nervous system. Nature. 319146:1986;146-150.
89. Vliagoftis H., Dimitriadou V., Boucher W., Rozniecki J.J., Correia I., Raam S., Theoharides T.C. Estradiol augments while tamoxifen inhibits rat mast cell secretion. Int. Arch. Allergy Immunol. 98:1992;398-409.
90. Walsh L.J., Trinchieri G., Waldorf H.A., Whitaker D., Murphy G.F. Human dermal mast cells contain and release tumor necrosis factor α, which induces endothelial leukocyte adhesion molecule 1. Proc. Natl. Acad. Sci. U.S.A. 88:1991;4220-4224.
91. Williams R.M., Bienenstock J., Stead R.H. Mast cells: the neuro immune connection. Chem. Immunol. 61:1995;208-235.
92. Williamson D.J., Shepheard S.L., Hill R.G., Hargreaves R.J. The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation. Eur. J. Pharmacol. 328:1997;61-64.